Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Generic medicine
Generic medicine

Empagliflozin

Empagliflozin

Data statusRegistration & price fields require source verification.
71brands/products
30companies
71with current prices
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

71 results
Reset
BrandManufacturerStrengthFormPackReg. no.Official price
EmpagenFerozsons Laboratories Limited25 mgTablet30's103100PKR 2,513.742026-07-22
EmpagliHigh-Q Pharmaceuticals10 mgTablet30's098697PKR 2,793.332025-08-18
EmpagliHigh-Q Pharmaceuticals25 mgTablet30's098696PKR 3,343.802025-08-18
EmpaphageMartin Dow Marker Limited10 mgTablet14's110219PKR 918.242026-07-23
EmpaphageMartin Dow Marker Limited25 mgTablet14's110220PKR 1,099.052026-07-23
EMPATORMartin Dow Limited10 mgTablet14's098822PKR 1,099.952026-07-22
EMPATORMartin Dow Limited25 mgTablet14's098823PKR 1,316.562026-07-22
EmpawerWerrick Pharmaceuticals25 mgTablet14's113915PKR 1,439.382025-08-18
EmpawerWerrick Pharmaceuticals10 mgTablet14's113914PKR 1,202.572025-08-18
EMPOLISAMI Pharmaceuticals Pvt. Ltd.25 mgTablet30's098701PKR 3,413.292026-07-23
EMPOLISAMI Pharmaceuticals Pvt. Ltd.10 mgTablet30's098702PKR 2,851.372026-07-23
EmpozinMacter International Limited10 mgTablet28's093078PKR 2,257.412026-07-23
EmpozinMacter International Limited25 mgTablet28's093077PKR 2,702.162026-07-23
EmsynThe Searle Company Limited25 mgTablet28’s093090PKR 2,770.092026-07-23
EmsynThe Searle Company Limited10 mgTablet28’s093089PKR 2,314.152026-07-23
ErliPHARMEVO (PVT) LTD.25 mgTablet14's098827PKR 1,316.562026-07-23
ErliPHARMEVO (PVT) LTD.10 mgTablet14's098826PKR 1,099.952026-07-23
GempazNovaMed Pharmaceuticals(Pvt.)Ltd25 mgTablet14's116561PKR 1,027.162026-07-23
GempazNovaMed Pharmaceuticals(Pvt.)Ltd10 mgTablet14's116560PKR 858.162026-07-23
GlempaNabiqasim Industries (Pvt) Ltd.,25 mgTablet14s110226PKR 1,099.062026-07-23
Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.